Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California
Public ClinicalTrials.gov record NCT05022472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Project 2VIDA! SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The United States (U.S.) is the country with the largest number of infections and deaths due to COVID- 19 and racial/ethnic minorities are disproportionately affected. Acceptance and uptake of COVID-19 vaccines will be instrumental to ending the pandemic. To this end, 2VIDA! (SARS-CoV-2 Vaccine Intervention Delivery for Adults in Southern California) is a multilevel intervention to address individual, social, and contextual factors related to access to, and acceptance of, the COVID-19 vaccine by implementing and assessing a COVID-19 vaccination protocol among Latino and African American (AA) adults (\>18 years old) in San Diego. 2VIDA! builds on our previous CBPR efforts and centers on conducting COVID-19 Individual awareness and education, linkages to medical and supportive services, and Community Outreach and Health Promotion in the intervention sites (Phase 1); and offering the COVID-19 vaccine to Latino and AA adults (\>18 years old) in federally-qualified health centers and pop-up vaccination stations in communities highly impacted by the pandemic and identifying individual and structural barriers to COVID-19 immunization (Phase 2).
Study identification
- NCT ID
- NCT05022472
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,051 participants
Conditions and interventions
Conditions
Interventions
- COVID-19 Individual Awareness and Education. Behavioral
- COVID-19 Community Outreach & Health Promotion. Behavioral
- COVID-19 Individual Health Education & Linkages to Medical and Supportive Services. Behavioral
- Pop-up community vaccination sites Biological
Behavioral · Biological
Eligibility (public fields only)
- Age range
- 16 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 15, 2021
- Primary completion
- Mar 28, 2024
- Completion
- Mar 28, 2024
- Last update posted
- Jun 5, 2025
2021 – 2024
United States locations
- U.S. sites
- 6
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Ysidro Health Chula Vista | Chula Vista | California | 91910 | — |
| Care View Health Center | San Diego | California | 92114 | — |
| San Ysidro Health Care View Health Center | San Diego | California | 92114 | — |
| San Ysidro Health Euclid | San Diego | California | 92114 | — |
| San Ysidro Health King-Chavez Health Center | San Diego | California | 92114 | — |
| San Ysidro Health | San Ysidro | California | 92173 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05022472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05022472 live on ClinicalTrials.gov.